We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
Cap. Flow
+$434M
Cap. Flow %
1.67%
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$189M
2
INTC icon
Intel
INTC
+$180M
3
APH icon
Amphenol
APH
+$132M
4
INTU icon
Intuit
INTU
+$106M
5
LUV icon
Southwest Airlines
LUV
+$86.2M

Top Sells

Rank Stock Value
1
FTNT icon
Fortinet
FTNT
+$221M
2
CEG icon
Constellation Energy
CEG
+$181M
3
UBER icon
Uber
UBER
+$169M
4
MA icon
Mastercard
MA
+$140M
5
EXC icon
Exelon
EXC
+$108M

Sector Composition

Rank Sector Weight
1 Technology 30.39%
2 Financials 14.25%
3 Consumer Discretionary 12.97%
4 Industrials 12.61%
5 Healthcare 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PL icon
601
Planet Labs
PL
$7.28B
$2M 0.01%
895,109
+487,958
+120% +$1.08M
MSBI icon
602
Midland States Bancorp
MSBI
$701M
$2M 0.01%
89,187
+21,416
+32% +$486K
RXT icon
603
Rackspace Technology
RXT
$993M
$2M 0.01%
814,624
+474,299
+139% +$1.15M
SRI icon
604
Stoneridge
SRI
$206M
$1.99M 0.01%
178,248
+3,748
+2% +$53.5K
ENTA icon
605
Enanta Pharmaceuticals
ENTA
$365M
$1.99M 0.01%
191,726
-2,841
-1% -$37.1K
WRBY icon
606
Warby Parker
WRBY
$3.2B
$1.97M 0.01%
120,815
-54,053
-31% -$814K
YMAB
607
DELISTED
Y-mAbs Therapeutics
YMAB
$1.97M 0.01%
149,681
– –
MDU icon
608
MDU Resources
MDU
$4.32B
$1.96M 0.01%
129,058
-41,536
-24% -$591K
LOPE icon
609
Grand Canyon Education
LOPE
$4.1B
$1.96M 0.01%
13,799
– –
AIP icon
610
Arteris
AIP
$1.33B
$1.95M 0.01%
253,211
+67,414
+36% +$520K
HTB
611
HomeTrust Bancshares
HTB
$860M
$1.95M 0.01%
57,227
-182
-0.3% -$6.14K
NPKI
612
NPK International
NPKI
$1.09B
$1.93M 0.01%
278,744
-58,610
-17% -$451K
ASIX icon
613
AdvanSix
ASIX
$559M
$1.91M 0.01%
62,930
+27,283
+77% +$743K
FR icon
614
First Industrial Realty Trust
FR
$8.68B
$1.91M 0.01%
34,041
+14,368
+73% +$774K
UPST icon
615
Upstart Holdings
UPST
$2.6B
$1.89M 0.01%
47,318
+23,073
+95% +$767K
THFF icon
616
First Financial Corp
THFF
$956M
$1.88M 0.01%
42,848
-6,640
-13% -$282K
MRSN
617
DELISTED
Mersana Therapeutics
MRSN
$1.88M 0.01%
39,722
+20,298
+104% +$896K
ACN icon
618
Accenture
ACN
$102B
$1.87M 0.01%
+5,278
New +$1.74M
MGNX icon
619
MacroGenics
MGNX
$244M
$1.86M 0.01%
566,328
+147,438
+35% +$574K
GOSS icon
620
Gossamer Bio
GOSS
$94.7M
$1.86M 0.01%
1,887,512
+442,895
+31% +$426K
CPS icon
621
Cooper-Standard Automotive
CPS
$557M
$1.86M 0.01%
133,862
-7,215
-5% -$100K
AVAH icon
622
Aveanna Healthcare
AVAH
$2.15B
$1.85M 0.01%
355,340
+265,969
+298% +$1.2M
GDRX icon
623
GoodRx Holdings
GDRX
$1.06B
$1.83M 0.01%
263,200
-30,398
-10% -$239K
EDIT icon
624
Editas Medicine
EDIT
$402M
$1.81M 0.01%
529,834
+302,652
+133% +$1.32M
PAG icon
625
Penske Automotive Group
PAG
$14.8B
$1.81M 0.01%
+11,116
New +$1.77M
23 24
25
26 27

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2024 Portfolio in Review

As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
  • Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
  • Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
  • Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
  • Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
  • Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.